Your address will show here +12 34 56 78
ABOUT CPE CAPITAL

CPE Capital (CPEC) is Australasia's most experienced private capital manager, having made 84 platform investments across $4.3 billion in funds since 1987.


CPEC’s long history of sustainable performance across all investment cycles is based on its ability to identify situations and opportunities that offer growth on a risk adjusted basis.  

30+
YEARS EXPERIENCE
84
PLATFORM INVESTMENTS
$4.3B
INVESTED SINCE 1987
  • Text Hover
I'M LOOKING FOR
INVESTMENT
I WANT TO
INVEST

NEWS

Surf education progr...

Modified nippers and surf education program, Dippers, continues its push to reduce the risk of drowning for those on the autism spectrum. The program, now in its 7th year, is being run again this summer at Coogee, Bondi, Bronte and Port Macquarie. Funding from organisational sponsorships, toget...

Leading sovereign de...

ASDAM today announced the acquisitions of TAE Aerospace (“TAE”) and RUAG Australia, which join Marand and Levett as part of the ASDAM Group. ASDAM has established an industry leading Australian sovereign industrial capability in engineering, advanced manufacturing and sustainment across defence, aer...

Gourmet Food spurred...

When Todd Wilson joined several friends from the corporate world in 2010 to form Gourmet Food Holdings, they were spurred on by what they saw as a gap in the market. “Product innovation was not occurring and retailers needed a new entrant to fill their demand for packaged seafood,” he explained. “We...

CPE Capital continue...

Dippers is a modified Nippers and surf education program that is open to all ages and abilities. The program was developed by Autism Swim (AS) and is run in collaboration with local Surf Life Saving Clubs (SLSC). The SLSC’s have a proven track record in water education and provide some of the volunt...

Exit of Cell Care

CPE Capital (CPEC) has sold Cell Care to Generate Life Sciences, the world’s largest provider of newborn stem cell services and reproductive tissue banks. During CPEC’s 2.5 year investment, Cell Care experienced consistent growth in EBITDA, including through the COVID-19 pandemic. The growth in...

OUR INVESTMENTS